MedDataX Logo

Multi-country, Multi-center Cohort Study of Anti-Mullerian Hormone Profile in Asia Pacific Infertile Patients

NCT ID: NCT04203355

Last Updated: 2019-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-01

Study Completion Date

2021-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to detect the infertile couple (women) Anti-Mullerian Hormone (AMH) profile in major subgroups such as Poly Cystic Ovarian Syndrome (PCOS), Endometriosis, etc via age intervals and ethnic difference.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To consecutively enroll infertile couple (women) who are undergoing their first controlled ovarian stimulation cycles.

To mainly compare the inter-ethnic difference in age-specific AMH profile in unexplained infertility, male factor infertility, PCOS, Endometriosis etc. subgroups.

To detect the influence of past or present smoking on age-specific AMH levels To study the influence of body mass index (BMI) on age specific AMH levels

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed as infertile couple
* Naive patients who plan to enter their first ovarian stimulation cycles
* Women among 20-43 years old

Exclusion Criteria

* Systematic disease that impact AMH (eg. systemic lupus erythematosus (SLE), Crohn's disease etc.)
* Chemotherapy history
* Alcohol abuse
* Currently taking oral contraceptive pills
Minimum Eligible Age

20 Years

Maximum Eligible Age

43 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chii-Ruey Tzeng, MD, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Taipei Medical University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Henan Provincial People Hospital

Zhengzhou, Henan, China

Site Status

Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status

Women's center by Motherhood Coimbatore

Bangalore, Karnataka, India

Site Status

Morula IVF center

Jakarta, , Indonesia

Site Status

Asada Ladies Clinic

Nagoya, Aichi-ken, Japan

Site Status

Tropicana Medical Centre

Petaling Jaya, Selangor, Malaysia

Site Status

Victory ART Lab Fertility Center

Makati City, , Philippines

Site Status

CHA Bundang Medical Center

Seongnam-si, Gyeonggi-do, South Korea

Site Status

Taipei University Medical Hospital

Taipei, , Taiwan

Site Status

Chiang Mai University

Chiang Mai, , Thailand

Site Status

My Duc Hospital

Ho Chi Minh City, , Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China Hong Kong India Indonesia Japan Malaysia Philippines South Korea Taiwan Thailand Vietnam

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chii-Ruey Tzeng, MD, Ph.D

Role: CONTACT

Phone: +88 622 737 2181

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cuilian Zhang, MD, PhD

Role: primary

Raymond HW Li, MD, PhD

Role: primary

Mirudhubashini Govindarajan, MD, Ph D

Role: primary

Ivan R Sini, MD

Role: primary

Yoshimasa Asada, MD, Ph D

Role: primary

Surinder Singh, MD

Role: primary

Gregorio B Pastorfide, MD

Role: primary

Ji Hyang Kim, MD. Ph. D

Role: primary

Chii-Ruey Tzeng, MD, Ph. D

Role: primary

Teraporn Vutyavanich, MD, Ph D

Role: primary

Ho Manh Tuong, MD, Ph D

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Tzeng CR, Huang Z, Asada Y, Zhang C, Ho MT, Li RHW, Kim JH, Govindarajan M, Vuyavanich T, Sini I, Wong PS, Singh S, Lin WY, Ho NT. Factors affecting the distribution of serum anti-mullerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study. Hum Reprod. 2023 Jul 5;38(7):1368-1378. doi: 10.1093/humrep/dead081.

Reference Type DERIVED
PMID: 37105234 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TMU201912130

Identifier Type: -

Identifier Source: org_study_id